Bruton's tyrosine kinase inhibitor BMS-986142 in experimental models of rheumatoid arthritis enhances efficacy of agents representing clinical standard-of-care
Kathleen M. Gillooly(Bristol-Myers Squibb (United States)), James R. Burke(Immunosciences Lab (United States))
Cited by 57
Related Papers
Tyrosine Kinase 2-mediated Signal Transduction in T Lymphocytes Is Blocked by Pharmacological Stabilization of Its Pseudokinase Domain
|Journal of Biological Chemistry|2015|116